BBC vs. NVDA

Last updated Apr 2, 2026

Compare and contrast key facts about Virtus LifeSci Biotech Clinical Trials ETF (BBC) and NVIDIA Corporation (NVDA).

BBC is a passively managed fund by Virtus Investment Partners that tracks the performance of the LifeSci Biotechnology Clinical Trials Index. It was launched on Dec 16, 2014.

Performance

BBC vs. NVDA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Virtus LifeSci Biotech Clinical Trials ETF (BBC) and NVIDIA Corporation (NVDA). The values are adjusted to include any dividend payments, if applicable.

BBC vs. NVDA - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
BBC Virtus LifeSci Biotech Clinical Trials ETF	10.01%	63.77%	-1.11%	-1.80%	-35.13%	-22.31%	30.32%	63.81%	-18.29%	57.85%
NVDA NVIDIA Corporation	-5.76%	38.92%	171.25%	239.02%	-50.26%	125.48%	122.30%	76.94%	-30.82%	81.99%

Returns By Period

In the year-to-date period, BBC achieves a 10.01% return, which is significantly higher than NVDA's -5.76% return. Over the past 10 years, BBC has underperformed NVDA with an annualized return of 8.62%, while NVDA has yielded a comparatively higher 69.75% annualized return.

BBC

• 1D: 1.91%
• 1M: 0.45%
• YTD: 10.01%
• 6M: 58.07%
• 1Y: 160.96%
• 3Y*: 25.88%
• 5Y*: -3.27%
• 10Y*: 8.62%

NVDA

• 1D: 0.77%
• 1M: -3.68%
• YTD: -5.76%
• 6M: -6.13%
• 1Y: 59.59%
• 3Y*: 85.01%
• 5Y*: 66.40%
• 10Y*: 69.75%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

BBC vs. NVDA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BBC

BBC Risk / Return Rank: 98
BBC Sharpe Ratio Rank: 99
BBC Sortino Ratio Rank: 98
BBC Omega Ratio Rank: 96
BBC Calmar Ratio Rank: 98
BBC Martin Ratio Rank: 98

NVDA

NVDA Risk / Return Rank: 82
NVDA Sharpe Ratio Rank: 83
NVDA Sortino Ratio Rank: 80
NVDA Omega Ratio Rank: 77
NVDA Calmar Ratio Rank: 86
NVDA Martin Ratio Rank: 84

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BBC vs. NVDA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Virtus LifeSci Biotech Clinical Trials ETF (BBC) and NVIDIA Corporation (NVDA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	BBC	NVDA	Difference
Sharpe ratio Return per unit of total volatility	4.05	1.45	+2.61
Sortino ratio Return per unit of downside risk	4.28	2.14	+2.14
Omega ratio Gain probability vs. loss probability	1.53	1.27	+0.26
Calmar ratio Return relative to maximum drawdown	8.09	3.08	+5.02
Martin ratio Return relative to average drawdown	29.69	7.73	+21.97
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

BBC vs. NVDA - Sharpe Ratio Comparison

The current BBC Sharpe Ratio is 4.05, which is higher than the NVDA Sharpe Ratio of 1.45. The chart below compares the historical Sharpe Ratios of BBC and NVDA, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	BBC	NVDA	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	4.05	1.45	+2.61
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.08	1.29	-1.37
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.23	1.40	-1.18
Sharpe Ratio (All Time) Calculated using the full available price history	0.12	0.61	-0.49

Correlation

The correlation between BBC and NVDA is 0.39, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

BBC vs. NVDA - Dividend Comparison

BBC's dividend yield for the trailing twelve months is around 1.55%, more than NVDA's 0.02% yield.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
BBC Virtus LifeSci Biotech Clinical Trials ETF	1.55%	1.70%	1.00%	0.34%	0.00%	0.00%	0.00%	0.00%	0.00%	2.09%	0.00%	0.51%
NVDA NVIDIA Corporation	0.02%	0.02%	0.03%	0.03%	0.11%	0.05%	0.12%	0.27%	0.46%	0.29%	0.45%	1.20%

Drawdowns

BBC vs. NVDA - Drawdown Comparison

The maximum BBC drawdown since its inception was -76.85%, smaller than the maximum NVDA drawdown of -89.72%. Use the drawdown chart below to compare losses from any high point for BBC and NVDA.

Drawdown Indicators

	BBC	NVDA	Difference
Max Drawdown Largest peak-to-trough decline	-76.85%	-89.72%	+12.87%
Max Drawdown (1Y) Largest decline over 1 year	-18.03%	-20.21%	+2.18%
Max Drawdown (5Y) Largest decline over 5 years	-72.58%	-66.34%	-6.24%
Max Drawdown (10Y) Largest decline over 10 years	-76.85%	-66.34%	-10.51%
Current Drawdown Current decline from peak	-29.38%	-15.10%	-14.28%
Average Drawdown Average peak-to-trough decline	-37.30%	-36.40%	-0.90%
Ulcer Index Depth and duration of drawdowns from previous peaks	4.91%	8.05%	-3.14%

Volatility

BBC vs. NVDA - Volatility Comparison

Virtus LifeSci Biotech Clinical Trials ETF (BBC) has a higher volatility of 13.12% compared to NVIDIA Corporation (NVDA) at 10.43%. This indicates that BBC's price experiences larger fluctuations and is considered to be riskier than NVDA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	BBC	NVDA	Difference
Volatility (1M) Calculated over the trailing 1-month period	13.12%	10.43%	+2.69%
Volatility (6M) Calculated over the trailing 6-month period	26.96%	25.79%	+1.17%
Volatility (1Y) Calculated over the trailing 1-year period	40.44%	41.42%	-0.98%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	39.31%	51.72%	-12.41%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	37.86%	49.84%	-11.98%